Abstract
Purpose
Patients with chronic kidney disease (CKD) have an associated burden of coronary artery disease, including chronic total occlusions (CTO). It is unclear how the presence of CKD affects the outcomes of CTO revascularization. Previous reviews have not taken into account all relevant published studies that examined the association of CKD with outcomes of CTO revascularization.
Methods
A systematic search was conducted using PubMed, Scopus, and Google Scholar databases for studies investigating patients with or without CKD who also had coronary chronic total occlusion undergoing revascularization procedures Statistical analysis was performed using STATA software. Effect sizes were reported as pooled relative risk (RR).
Results
A total of 13 studies were included. CKD patients showed elevated risk of in-hospital mortality (RR 4.25, 95% CI 2.64, 6.82) and mortality at latest follow-up (RR 3.24, 95% CI 2.56, 4.11), elevated risk of major cardio or cerebrovascular events (RR 1.65, 95% CI 1.38, 1.98), major bleeding (RR 2.85, 95% CI 1.96, 4.13), and contrast-induced acute kidney injury (RR 3.06, 95% CI 1.70, 5.52). CKD patients also showed lower chances of technical success (RR 0.95, 95% CI 0.91, 1.00).
Conclusions
The presence of CKD increases the risk of mortality, complications and adversely affects the success of CTO revascularization. Patients with CKD undergoing revascularization should have their kidney function comprehensively evaluated and these patients should be carefully monitored.
Similar content being viewed by others
Data availability
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Werner GS, Gitt AK, Zeymer U et al (2009) Chronic total coronary occlusions in patients with stable angina pectoris: impact on therapy and outcome in present day clinical practice. Clin Res Cardiol 98:435–441. https://doi.org/10.1007/s00392-009-0013-5
Irving J (2014) CTO pathophysiology: how does this affect management? Curr Cardiol Rev 10:99–107. https://doi.org/10.2174/1573403x10666140331142349
Kearney K, Hira RS, Riley RF et al (2017) Update on the management of chronic total occlusions in coronary artery disease. Curr Atheroscler Rep 19:19. https://doi.org/10.1007/s11883-017-0655-0
Weintraub WS, Garratt KN (2016) Should chronic total occlusion be treated with coronary artery bypass grafting? Circulation 133:1818–1825. https://doi.org/10.1161/CIRCULATIONAHA.115.017798
Ybarra LF, Cantarelli MJC, Lemke VMG, de Quadros AS (2018) Percutaneous coronary intervention in chronic total occlusion. Arq Bras Cardiol 110:476–483. https://doi.org/10.5935/abc.20180077
Subbiah AK, Chhabra YK, Mahajan S (2016) Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup. Heart Asia 8:56–61. https://doi.org/10.1136/heartasia-2016-010809
Briasoulis A, Bakris GL (2013) Chronic kidney disease as a coronary artery disease risk equivalent. Curr Cardiol Rep 15:340. https://doi.org/10.1007/s11886-012-0340-4
Cooper WA, O’Brien SM, Thourani VH et al (2006) Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 113:1063–1070. https://doi.org/10.1161/CIRCULATIONAHA.105.580084
Tsai TT, Messenger JC, Brennan JM et al (2011) Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI registry-CMS claims database. J Am Coll Cardiol 58:1859–1869. https://doi.org/10.1016/j.jacc.2011.06.056
Muntner P, He J, Hamm L et al (2002) Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13:745–753. https://doi.org/10.1681/ASN.V133745
Campbell NG, Varagunam M, Sawhney V et al (2012) Mild chronic kidney disease is an independent predictor of long-term mortality after emergency angiography and primary percutaneous intervention in patients with ST-elevation myocardial infarction. Heart 98:42–47. https://doi.org/10.1136/heartjnl-2011-300024
Giustino G, Mehran R, Serruys PW et al (2018) Left main revascularization with PCI or CABG in Patients with chronic kidney disease: EXCEL trial. J Am Coll Cardiol 72:754–765. https://doi.org/10.1016/j.jacc.2018.05.057
Sarnak MJ, Levey AS, Schoolwerth AC et al (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 42:1050–1065. https://doi.org/10.1161/01.HYP.0000102971.85504.7c
Wali RK, Henrich WL (2005) Chronic kidney disease: a risk factor for cardiovascular disease. Cardiol Clin 23:343–362. https://doi.org/10.1016/j.ccl.2005.03.007
Levey AS, Beto JA, Coronado BE et al (1998) Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32:853–906. https://doi.org/10.1016/s0272-6386(98)70145-3
Aktürk E, Aşkın L, Taşolar H et al (2019) Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions. Interv Med Appl Sci 11:95–100. https://doi.org/10.1556/1646.11.2019.15
Moroni F, Spangaro A, Carlino M et al (2020) Impact of renal function on the immediate and long-term outcomes of percutaneous recanalization of coronary chronic total occlusions: a systematic review and meta-analysis. Int J Cardiol 317:200–206. https://doi.org/10.1016/j.ijcard.2020.05.067
Farrukh Mustafa S, Zafar MR, Vira A et al (2021) In-hospital outcomes of patients with chronic kidney disease undergoing percutaneous coronary intervention for chronic total occlusion: a systematic review and meta-analysis. Coron Artery Dis. https://doi.org/10.1097/MCA.0000000000001026
Lee W-C, Wu P-J, Fang C-Y et al (2021) Impact of chronic kidney disease on chronic total occlusion revascularization outcomes: a meta-analysis. J Clin Med 10:440. https://doi.org/10.3390/jcm10030440
PRISMA. http://www.prisma-statement.org/PRISMAStatement/. Accessed 11 Sep 2021
Wells G, Shea B, O’Connell D, et al The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. 21
Higgins JPT, Green S Cochrane Handbook for Systematic Reviews of Interventions. https://handbook-5-1.cochrane.org/. Accessed 22 Aug 2021
Malik AO, Spertus JA, Grantham JA et al (2020) Outcomes of chronic total occlusion percutaneous coronary intervention in patients with renal dysfunction. Am J Cardiol 125:1046–1053. https://doi.org/10.1016/j.amjcard.2019.12.045
Guo L, Ding H, Lv H et al (2020) Impact of renal function on long-term clinical outcomes in patients with coronary chronic total occlusions: results from an observational single-center cohort study during the last 12 years. Front Cardiovasc Med 7:550428. https://doi.org/10.3389/fcvm.2020.550428
Li B, Rong J, Wang B et al (2020) Cystatin C-based renal function in predicting the long-term outcomes of chronic total occlusion after percutaneous coronary intervention. Front Cardiovasc Med 7:221. https://doi.org/10.3389/fcvm.2020.586181
Flores-Umanzor E, Cepas-Guillen P, Álvarez-Contreras L et al (2021) Impact of chronic kidney disease in chronic total occlusion management and clinical outcomes. Cardiovasc Revasc Med S1553–8389(21):00545–00555. https://doi.org/10.1016/j.carrev.2021.07.018
Shimura T, Yamamoto M, Tsuchikane E et al (2016) Rates of future hemodialysis risk and beneficial outcomes for patients with chronic kidney disease undergoing recanalization of chronic total occlusion. Int J Cardiol 222:707–713. https://doi.org/10.1016/j.ijcard.2016.08.019
Azzalini L, Ojeda S, Demir OM et al (2018) Recanalization of chronic total occlusions in patients with vs without chronic kidney disease: the impact of contrast-induced acute kidney injury. Can J Cardiol 34:1275–1282. https://doi.org/10.1016/j.cjca.2018.07.012
Tajti P, Karatasakis A, Danek BA et al (2018) In-hospital outcomes of chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease. J Invasive Cardiol 30:E113–E121
Stähli BE, Gebhard C, Gick M et al (2018) Outcomes after percutaneous coronary intervention for chronic total occlusion according to baseline renal function. Clin Res Cardiol 107:259–267. https://doi.org/10.1007/s00392-017-1179-x
Aguiar-Souto P, Ferrante G, Del Furia F et al (2010) Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions. Int J Cardiol 139:68–74. https://doi.org/10.1016/j.ijcard.2008.10.006
Lin Y-S, Fang H-Y, Hussein H et al (2014) Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention. EuroIntervention 9:1173–1180. https://doi.org/10.4244/EIJV9I10A198
Zhang Q-B, Chen L-M, Li M et al (2016) Influence of chronic kidney disease on the outcome of patients with chronic total occlusion. Am J Transl Res 8:196–208
Naganuma T, Tsujita K, Mitomo S et al (2018) Impact of chronic kidney disease on outcomes after percutaneous coronary intervention for chronic total occlusions (from the Japanese Multicenter Registry). Am J Cardiol 121:1519–1523. https://doi.org/10.1016/j.amjcard.2018.02.032
Scholz SS, Lauder L, Ewen S et al (2020) One-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registry. Clin Res Cardiol 109:845–856. https://doi.org/10.1007/s00392-019-01575-y
Tonelli M, Wiebe N, Culleton B et al (2006) Chronic kidney disease and mortality risk: a systematic review. JASN 17:2034–2047. https://doi.org/10.1681/ASN.2005101085
Shlipak MG, Fried LF, Crump C et al (2003) Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107:87–92. https://doi.org/10.1161/01.cir.0000042700.48769.59
Raggi P, Boulay A, Chasan-Taber S et al (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39:695–701. https://doi.org/10.1016/s0735-1097(01)01781-8
McCullough PA, Adam A, Becker CR et al (2006) Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 98:5K-13K. https://doi.org/10.1016/j.amjcard.2006.01.019
Tsai TT, Patel UD, Chang TI et al (2014) Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv 7:1–9. https://doi.org/10.1016/j.jcin.2013.06.016
Acknowledgements
None.
Funding
No funding was received.
Author information
Authors and Affiliations
Contributions
YQ and JH conceptualized and designed the study; YQ and JH did literature search and data collection; MP and JY analysed the data; MP and JY wrote the paper; YQ and JH Reviewed and edited the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Qi, Y., He, J., Pan, M. et al. Impact of impaired renal function on outcomes of chronic total occlusion undergoing revascularization: a systemic review and meta-analysis. Int Urol Nephrol 54, 3179–3191 (2022). https://doi.org/10.1007/s11255-022-03192-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-022-03192-7